- cafead   Jan 31, 2024 at 12:12: PM
via GSK (GSK.L), beat market estimates for fourth-quarter results on Wednesday, and unveiled an upbeat forecast for 2024 and beyond on the ramp-up of its vaccines and cancer drugs pipeline, underscoring the benefits of its consumer health unit spin-off.
article source
article source